Drugs that contain Oxybutynin
1. List of Gelnique 3% drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7198801 | ALLERGAN | Formulations for transdermal or transmucosal application |
Jun, 2022
(11 months ago) | |
Do you want to check out GELNIQUE 3% patents from before 2022?
Market Authorisation Date: 07 December, 2011
Treatment: NA
Dosage: GEL, METERED;TRANSDERMAL
More Information on Dosage
GELNIQUE 3% family patents
18
United States
10
European Union
4
Austria
4
Japan
4
Australia
3
Spain
3
Germany
3
Canada
3
New Zealand
3
Mexico
2
China
2
Brazil
2
Korea, Republic of
2
South Africa
1
Hong Kong
1
Denmark
1
Poland
1
Argentina
1
Israel
1
Portugal
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic